808 related articles for article (PubMed ID: 21626257)
21. Radiofrequency ablation for stage I non-small cell lung cancer: management of locoregional recurrence.
Lanuti M; Sharma A; Willers H; Digumarthy SR; Mathisen DJ; Shepard JA
Ann Thorac Surg; 2012 Mar; 93(3):921-7; discussion 927-88. PubMed ID: 22296982
[TBL] [Abstract][Full Text] [Related]
22. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.
Koshy M; Fedewa SA; Malik R; Ferguson MK; Vigneswaran WT; Feldman L; Howard A; Abdelhady K; Weichselbaum RR; Virgo KS
J Thorac Oncol; 2013 Jul; 8(7):915-22. PubMed ID: 23608815
[TBL] [Abstract][Full Text] [Related]
23. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
24. Age and treatment of non-small-cell lung cancer: a database analysis in elderly patients.
Berghmans T; Tragas G; Sculier JP
Support Care Cancer; 2002 Nov; 10(8):619-23. PubMed ID: 12436220
[TBL] [Abstract][Full Text] [Related]
25. Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer.
Davidoff AJ; Gardner JF; Seal B; Edelman MJ
J Thorac Oncol; 2011 May; 6(5):934-41. PubMed ID: 21372743
[TBL] [Abstract][Full Text] [Related]
26. Concurrent chemotherapy and short course radiotherapy in patients with stage IIIA to IIIB non-small cell lung cancer not eligible for radical treatment: results of a randomized phase II study.
Nawrocki S; Krzakowski M; Wasilewska-Tesluk E; Kowalski D; Rucinska M; Dziadziuszko R; Sowa A
J Thorac Oncol; 2010 Aug; 5(8):1255-62. PubMed ID: 20592630
[TBL] [Abstract][Full Text] [Related]
27. Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.
Stinchcombe TE; Morris DE; Moore DT; Bechtel JH; Halle JS; Mears A; Deschesne K; Rosenman JG; Socinski MA
Lung Cancer; 2006 Apr; 52(1):67-74. PubMed ID: 16499996
[TBL] [Abstract][Full Text] [Related]
28. Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial.
Palussière J; Chomy F; Savina M; Deschamps F; Gaubert JY; Renault A; Bonnefoy O; Laurent F; Meunier C; Bellera C; Mathoulin-Pelissier S; de Baere T
J Cardiothorac Surg; 2018 Aug; 13(1):91. PubMed ID: 30143031
[TBL] [Abstract][Full Text] [Related]
29. Twelve-year follow-up of trimodality therapy for stage IIIA non-small cell lung cancer.
Weitberg AB; Liu L; Yashar J; Glicksman AS
J Exp Clin Cancer Res; 2001 Sep; 20(3):335-40. PubMed ID: 11718211
[TBL] [Abstract][Full Text] [Related]
30. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer.
Zemlyak A; Moore WH; Bilfinger TV
J Am Coll Surg; 2010 Jul; 211(1):68-72. PubMed ID: 20610251
[TBL] [Abstract][Full Text] [Related]
31. Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
Friedel G; Budach W; Dippon J; Spengler W; Eschmann SM; Pfannenberg C; Al-Kamash F; Walles T; Aebert H; Kyriss T; Veit S; Kimmich M; Bamberg M; Kohlhaeufl M; Steger V; Hehr T
J Clin Oncol; 2010 Feb; 28(6):942-8. PubMed ID: 20100967
[TBL] [Abstract][Full Text] [Related]
32. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].
Yu DP; Bai LQ; Xu SF; Han M; Wang ZT
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561
[TBL] [Abstract][Full Text] [Related]
33. Progress in standard of care therapy and modest survival benefits in the treatment of non-small cell lung cancer patients in the Netherlands in the last 20 years.
van der Drift MA; Karim-Kos HE; Siesling S; Groen HJ; Wouters MW; Coebergh JW; de Vries E; Janssen-Heijnen ML
J Thorac Oncol; 2012 Feb; 7(2):291-8. PubMed ID: 22157366
[TBL] [Abstract][Full Text] [Related]
34. Oral vinorelbine and cisplatin with concurrent radiotherapy after induction chemotherapy with cisplatin and docetaxel for patients with locally advanced non-small cell lung cancer: the GFPC 05-03 study.
Descourt R; Vergnenegre A; Barlesi F; Lena H; Fournel P; Falchero L; Berard H; Hureaux J; Le Caer H; Chavaillon JM; Geriniere L; Monnet I; Chouabe S; Robinet G;
J Thorac Oncol; 2011 Feb; 6(2):351-7. PubMed ID: 21164367
[TBL] [Abstract][Full Text] [Related]
35. Reduction in Tumor Volume by Cone Beam Computed Tomography Predicts Overall Survival in Non-Small Cell Lung Cancer Treated With Chemoradiation Therapy.
Jabbour SK; Kim S; Haider SA; Xu X; Wu A; Surakanti S; Aisner J; Langenfeld J; Yue NJ; Haffty BG; Zou W
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):627-33. PubMed ID: 26068495
[TBL] [Abstract][Full Text] [Related]
36. Postoperative radiotherapy increases locoregional control of patients with stage IIIA non-small-cell lung cancer treated with induction chemotherapy followed by surgery.
Taylor NA; Liao ZX; Stevens C; Walsh G; Roth J; Putnam J; Fossella F; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):616-25. PubMed ID: 12788166
[TBL] [Abstract][Full Text] [Related]
37. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer.
Dupuy DE; DiPetrillo T; Gandhi S; Ready N; Ng T; Donat W; Mayo-Smith WW
Chest; 2006 Mar; 129(3):738-45. PubMed ID: 16537876
[TBL] [Abstract][Full Text] [Related]
38. Value of combined interpretation of computed tomography response and positron emission tomography response for prediction of prognosis after neoadjuvant chemotherapy in non-small cell lung cancer.
Lee HY; Lee HJ; Kim YT; Kang CH; Jang BG; Chung DH; Goo JM; Park CM; Lee CH; Kang KW
J Thorac Oncol; 2010 Apr; 5(4):497-503. PubMed ID: 20195167
[TBL] [Abstract][Full Text] [Related]
39. Outcome of treated advanced non-small cell lung cancer with and without central airway obstruction.
Chhajed PN; Baty F; Pless M; Somandin S; Tamm M; Brutsche MH
Chest; 2006 Dec; 130(6):1803-7. PubMed ID: 17167000
[TBL] [Abstract][Full Text] [Related]
40. Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo.
Giladi M; Weinberg U; Schneiderman RS; Porat Y; Munster M; Voloshin T; Blatt R; Cahal S; Itzhaki A; Onn A; Kirson ED; Palti Y
Semin Oncol; 2014 Oct; 41 Suppl 6():S35-41. PubMed ID: 25213867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]